Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential. / Riedl, Petra; Wieland, Andreas; Lamberth, Kasper; Buus, Søren; Lemonnier, Francois; Reifenberg, Kurt; Reimann, Jörg; Schirmbeck, Reinhold.

I: Journal of Immunology, Bind 183, Nr. 1, 2009, s. 370-80.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Riedl, P, Wieland, A, Lamberth, K, Buus, S, Lemonnier, F, Reifenberg, K, Reimann, J & Schirmbeck, R 2009, 'Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential', Journal of Immunology, bind 183, nr. 1, s. 370-80. https://doi.org/10.4049/jimmunol.0900505

APA

Riedl, P., Wieland, A., Lamberth, K., Buus, S., Lemonnier, F., Reifenberg, K., Reimann, J., & Schirmbeck, R. (2009). Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential. Journal of Immunology, 183(1), 370-80. https://doi.org/10.4049/jimmunol.0900505

Vancouver

Riedl P, Wieland A, Lamberth K, Buus S, Lemonnier F, Reifenberg K o.a. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential. Journal of Immunology. 2009;183(1):370-80. https://doi.org/10.4049/jimmunol.0900505

Author

Riedl, Petra ; Wieland, Andreas ; Lamberth, Kasper ; Buus, Søren ; Lemonnier, Francois ; Reifenberg, Kurt ; Reimann, Jörg ; Schirmbeck, Reinhold. / Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential. I: Journal of Immunology. 2009 ; Bind 183, Nr. 1. s. 370-80.

Bibtex

@article{4be74920779711df928f000ea68e967b,
title = "Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential",
abstract = "Immunodominance limits the TCR diversity of specific antiviral CD8 T cell responses elicited by vaccination or infection. To prime multispecific T cell responses, we constructed DNA vaccines that coexpress chimeric, multidomain Ags (with CD8 T cell-defined epitopes of the hepatitis B virus (HBV) surface (S), core (C), and polymerase (Pol) proteins and/or the OVA Ag as stress protein-capturing fusion proteins. Priming of mono- or multispecific, HLA-A*0201- or K(b)-restricted CD8 T cell responses by these DNA vaccines differed. K(b)/OVA(257-264)- and K(b)/S(190-197)-specific CD8 T cell responses did not allow priming of a K(b)/C(93-100)-specific CD8 T cell response in mice immunized with multidomain vaccines. Tolerance to the S- Ag in transgenic Alb/HBs mice (that express large amounts of transgene-encoded S- Ag in the liver) facilitated priming of subdominant, K(b)/C(93-100)-specific CD8 T cell immunity by multidomain Ags. The {"}weak{"} (i.e., easily suppressed) K(b)/C(93-100)-specific CD8 T cell response was efficiently elicited by a HBV core Ag-encoding vector in 1.4HBV-S(mut) tg mice (that harbor a replicating HBV genome that produces HBV surface, core, and precore Ag in the liver). K(b)/C(93-100)-specific CD8 T cells accumulated in the liver of vaccinated 1.4HBV-S(mut) transgenic mice where they suppressed HBV replication. Subdominant epitopes in vaccines can hence prime specific CD8 T cell immunity in a tolerogenic milieu that delivers specific antiviral effects to HBV-expressing hepatocytes.",
author = "Petra Riedl and Andreas Wieland and Kasper Lamberth and S{\o}ren Buus and Francois Lemonnier and Kurt Reifenberg and J{\"o}rg Reimann and Reinhold Schirmbeck",
note = "Keywords: Animals; Antigens, Polyomavirus Transforming; CD8-Positive T-Lymphocytes; Cell Line; Epitopes, T-Lymphocyte; Female; H-2 Antigens; HSP70 Heat-Shock Proteins; Hepatitis B Core Antigens; Hepatitis B Vaccines; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunodominant Epitopes; Liver Diseases; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Protein Binding; Protein Structure, Tertiary; Vaccines, DNA; Virus Replication",
year = "2009",
doi = "10.4049/jimmunol.0900505",
language = "English",
volume = "183",
pages = "370--80",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "1",

}

RIS

TY - JOUR

T1 - Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential

AU - Riedl, Petra

AU - Wieland, Andreas

AU - Lamberth, Kasper

AU - Buus, Søren

AU - Lemonnier, Francois

AU - Reifenberg, Kurt

AU - Reimann, Jörg

AU - Schirmbeck, Reinhold

N1 - Keywords: Animals; Antigens, Polyomavirus Transforming; CD8-Positive T-Lymphocytes; Cell Line; Epitopes, T-Lymphocyte; Female; H-2 Antigens; HSP70 Heat-Shock Proteins; Hepatitis B Core Antigens; Hepatitis B Vaccines; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunodominant Epitopes; Liver Diseases; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Protein Binding; Protein Structure, Tertiary; Vaccines, DNA; Virus Replication

PY - 2009

Y1 - 2009

N2 - Immunodominance limits the TCR diversity of specific antiviral CD8 T cell responses elicited by vaccination or infection. To prime multispecific T cell responses, we constructed DNA vaccines that coexpress chimeric, multidomain Ags (with CD8 T cell-defined epitopes of the hepatitis B virus (HBV) surface (S), core (C), and polymerase (Pol) proteins and/or the OVA Ag as stress protein-capturing fusion proteins. Priming of mono- or multispecific, HLA-A*0201- or K(b)-restricted CD8 T cell responses by these DNA vaccines differed. K(b)/OVA(257-264)- and K(b)/S(190-197)-specific CD8 T cell responses did not allow priming of a K(b)/C(93-100)-specific CD8 T cell response in mice immunized with multidomain vaccines. Tolerance to the S- Ag in transgenic Alb/HBs mice (that express large amounts of transgene-encoded S- Ag in the liver) facilitated priming of subdominant, K(b)/C(93-100)-specific CD8 T cell immunity by multidomain Ags. The "weak" (i.e., easily suppressed) K(b)/C(93-100)-specific CD8 T cell response was efficiently elicited by a HBV core Ag-encoding vector in 1.4HBV-S(mut) tg mice (that harbor a replicating HBV genome that produces HBV surface, core, and precore Ag in the liver). K(b)/C(93-100)-specific CD8 T cells accumulated in the liver of vaccinated 1.4HBV-S(mut) transgenic mice where they suppressed HBV replication. Subdominant epitopes in vaccines can hence prime specific CD8 T cell immunity in a tolerogenic milieu that delivers specific antiviral effects to HBV-expressing hepatocytes.

AB - Immunodominance limits the TCR diversity of specific antiviral CD8 T cell responses elicited by vaccination or infection. To prime multispecific T cell responses, we constructed DNA vaccines that coexpress chimeric, multidomain Ags (with CD8 T cell-defined epitopes of the hepatitis B virus (HBV) surface (S), core (C), and polymerase (Pol) proteins and/or the OVA Ag as stress protein-capturing fusion proteins. Priming of mono- or multispecific, HLA-A*0201- or K(b)-restricted CD8 T cell responses by these DNA vaccines differed. K(b)/OVA(257-264)- and K(b)/S(190-197)-specific CD8 T cell responses did not allow priming of a K(b)/C(93-100)-specific CD8 T cell response in mice immunized with multidomain vaccines. Tolerance to the S- Ag in transgenic Alb/HBs mice (that express large amounts of transgene-encoded S- Ag in the liver) facilitated priming of subdominant, K(b)/C(93-100)-specific CD8 T cell immunity by multidomain Ags. The "weak" (i.e., easily suppressed) K(b)/C(93-100)-specific CD8 T cell response was efficiently elicited by a HBV core Ag-encoding vector in 1.4HBV-S(mut) tg mice (that harbor a replicating HBV genome that produces HBV surface, core, and precore Ag in the liver). K(b)/C(93-100)-specific CD8 T cells accumulated in the liver of vaccinated 1.4HBV-S(mut) transgenic mice where they suppressed HBV replication. Subdominant epitopes in vaccines can hence prime specific CD8 T cell immunity in a tolerogenic milieu that delivers specific antiviral effects to HBV-expressing hepatocytes.

U2 - 10.4049/jimmunol.0900505

DO - 10.4049/jimmunol.0900505

M3 - Journal article

C2 - 19542448

VL - 183

SP - 370

EP - 380

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 1

ER -

ID: 20294795